Brief: Nextcell Pharma: Anders Essen-Möller And Diamyd Medical Increases Stakes In Co

NextCell Pharma AB

11/06/2019 11:08

June 11 (Reuters) - Nextcell Pharma Ab  NXTCL.TE :
    * ANDERS ESSEN-MÖLLER SUBSCRIBES TO HIS ENTIRE STAKES IN
NEXTCELL
PHARMAS RIGHT ISSUE
    * NEXTCELL PHARMA - ESSEN-MÖLLERS OWNERSHIP IN CO AFTER
INVESTMENTS INCREASES FROM ABOUT SEK 3.6 MILLION TO 6.0 MILLION
    * DIAMYD MEDICAL AND ANDERS ESSEN-MÖLLER THEREBY INCREASE
THEIR
HOLDINGS FROM 1,472,091 SHARES AND 1,105,918 SHARES TO 2,453,485
SHARES AND 1,843,197 SHARES, RESPECTIVELY
    * DIAMYD MEDICAL'S HOLDING IN NEXTCELL PHARMA INCREASES FROM
APPROXIMATELY SEK 5.4 MILLION TO APPROXIMATELY SEK 8.6 MILLION
    * NEXTCELL PHARMA - NEXTCELL'S CEO, MATHIAS SVAHN SUBSCRIBES
122,398 SHARES VIA HIS CO AND 27,166 SHARES PRIVATELY, TOTAL OF
149,564 SHARES TO VALUE OF SEK 0.5 MILLION

Source text for Eikon:  ID:nWkr3tMJqK 
Further company coverage:  NXTCL.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))